INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
Industrialising Drug Delivery
175
Issue No #175 July 2025
July 2nd, 2025
Download PDF
Issue 175 - Jul 2025
Inside the magazine
INDUSTRIALISATION
Philipp Richard
Ypsomed
SELF-INJECTION DEVICE MANUFACTURING IN A DYNAMIC WORLD
Philipp Richard scrutinises the efficient production of self-injection devices in the pharma industry and describes Ypsomed’s own platforms for developing these devices, highlighting the need to be adaptable and resilient to the rapidly evolving world of drug development. He provides valuable insights into the ways in which the flexible manufacture of self-injection devices might be achieved.
INTERVIEW
Gilbert Fluetsch
SHL Advantec
Interview: SHL Advantec – SHL Medical’s New Manufacturing Equipment Sub-Group
Gilbert Fluetsch discusses the establishment of SHL Advantec and the foundation it has built as SHL Medical’s in-house equipment specialist. Mr Fluetsch also looks at the role of modular platforms in scaling production and how the company’s global network is designed to support the changing landscape of medical and pharma manufacturing.
INDUSTRIALISATION
Lauren Orme
West Pharmaceutical Services
FINDING COMMON GROUND: FACTORS FOR ESTABLISHING AND SAFEGUARDING SHELF LIFE IN COMBINATION PRODUCTS
Lauren Orme discusses the regulatory considerations that need to be taken into account when designing combination products. She reviews the essential testing and standards required for both drug and device when establishing their shelf life and storage in a combined product.
INTERVIEW
Glenn Svedberg
Nolato Group
Interview From Pilot to Scale Manufacturing
In this second exclusive interview with ONdrugDelivery, Glenn Svedberg talks with Guy Furness about Nolato’s role as a strategic partner for design, development and industrialisation within the pharmaceutical sector. In an engaging conversation, Mr Svedberg covers a wide range of subjects about Notalo, including the company’s virtual factory, decentralised structure, approach to scaling up from single-cavity moulds to commercial production, regulatory expertise and global footprint, discussing how the company can use each of these elements to support its partners’ device development and industrialisation programmes.
INDUSTRIALISATION
Louise Righton
Bespak
SHORTENING AND DECARBONISING THE INHALATION SUPPLY CHAIN
Louise Righton examines the potential for reducing emissions across the pMDI supply chain, considering the localisation of suppliers to shorten supply chains as well as strong partnerships for developing novel, low-carbon alternatives to current high-emission pMDI manufacturing processes.
INDUSTRIALISATION
Adam Nightingale
Sanner Group
CDMOs AS STRATEGIC ENABLERS FOR DEVICE INDUSTRIALISATION
Adam Nightingale explores a multitude of approaches to achieving more efficient and sustainable production of medical devices when partnering with a CDMO, and demonstrates the ways in which these partnerships can offer reduced risk and comply with regulations when streamlining industrialisation.
INTERVIEW
Brian Thompson
Phillips Medisize
Interview: Phillips Medisize Grows its Capabilities with Vectura
In this exclusive interview with ONdrugDelivery’s Guy Furness, Brian Thompson and Dave Thoreson discuss Phillips Medisize’s expanded capabilities as a result of its recent acquisition of Vectura, bringing extensive expertise and experience in the inhalation sector within the global CDMO. The discussion covers how Phillips Medisize organises its global operations, the opportunities that the acquisition of Vectura represents and where the company goes next.
EXPERT VIEW
Jennifer Gattari
MASTERING COMMERCIAL MANUFACTURING FOR STERILE INJECTABLES
Jennifer Gattari delves into what is required to succeed at the commercial phase of sterile injectable manufacturing, going on to explore the challenges that companies can expect and the critical strategies that can help ensure a smooth and scalable journey to market.
EXPERT VIEW
Jacob Tyson
PRESSURE ON THE SUPPLY CHAIN: TARIFFS, REGULATIONS AND TRANSPARENCY
Jacob Tyson and Jon Lawrence consider the changes in the regulatory landscape for medical device manufacturers; the critical role that suppliers, distributors and importers play in ensuring effective post-market surveillance; and the technologies that companies are adopting to support traceability solutions.
EXPERT VIEW
Dr Richard Parmee
HARNESSING X-RAY AND AI FOR A NEW ERA OF QUALITY CONTROL
Dr Richard Parmee discusses the multitudinous applications of X-ray inspection technology for high-speed pharmaceutical production lines, covering the value of introducing artificial intelligence and machine learning techniques to enhance detection and improve safety.
Top
